Drug Development from Marine Resources

Marine organisms, including sponges, corals, and marine microbes, are a rich source of novel bioactive compounds with therapeutic potential. Marine-derived drugs have shown promise in treating a variety of diseases, particularly cancer, infections, and neurodegenerative disorders. Compounds like trabectedin (anticancer) and eflornithine (antimalarial) highlight the success of marine bioprospecting. Advances in marine biotechnology now enable sustainable production of these compounds, overcoming challenges in sourcing and scaling. With ongoing research and innovations in drug delivery systems and biotechnology, marine resources continue to provide valuable leads for the development of new, effective pharmaceuticals.

 

    Related Conference of Drug Development from Marine Resources

    October 27-28, 2025

    14th International Conference on Herbal Medicine and Acupuncture

    Amsterdam, Netherlands
    November 03-04, 2025

    5th World Medicine Congress

    Rome, Italy
    November 21-22, 2025

    5th International Conference on Medical Research and Development

    Amsterdam, Netherlands
    November 25-26, 2025

    21st World Summit on Blockchain Technology

    Amsterdam, Netherlands
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    May 18-19, 2026

    16th Annual Congress on Clinical and Medical Case Reports

    Aix-en-Provence, France
    October 19-20, 2026

    12th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France

    Drug Development from Marine Resources Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in